Pollard, J. A., Loken, M., Gerbing, R. B., Raimondi, S. C., Hirsch, B. A., Aplenc, R., . . . Meshinchi, S. (2016). CD33 Expression and Its Association With Gemtuzumab Ozogamicin Response: Results From the Randomized Phase III Children’s Oncology Group Trial AAML0531. J Clin Oncol.
Chicago Style CitationPollard, Jessica A., et al. "CD33 Expression and Its Association With Gemtuzumab Ozogamicin Response: Results From the Randomized Phase III Children’s Oncology Group Trial AAML0531." J Clin Oncol 2016.
Cita MLAPollard, Jessica A., et al. "CD33 Expression and Its Association With Gemtuzumab Ozogamicin Response: Results From the Randomized Phase III Children’s Oncology Group Trial AAML0531." J Clin Oncol 2016.
Atenció: Aquestes cites poden no estar 100% correctes.